| Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN) T Jamaspishvili, PG Patel, Y Niu, T Vidotto, I Caven, R Livergant, W Fu, ... JNCI: Journal of the National Cancer Institute 112 (11), 1098-1104, 2020 | 26 | 2020 |
| High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohorts SA Harmon, PG Patel, TH Sanford, I Caven, R Iseman, T Vidotto, ... Modern Pathology 34 (2), 478-489, 2021 | 18 | 2021 |
| Cognitive behavioral therapies for individuals with cerebral palsy: A scoping review T Silberg, N Kapil, I Caven, D Levac, D Fehlings Developmental Medicine & Child Neurology, 2023 | 5 | 2023 |
| Deep learning-based approach for automated assessment of PTEN status. T Jamaspishvili, S Harmon, P Patel, T Sanford, I Caven, R Iseman, ... Journal of Clinical Oncology 38 (6_suppl), 294-294, 2020 | 1 | 2020 |
| Autistic Perspectives on the Acceptability of Pediatric Autism Therapies I Caven, Y Hamdani, M Penner INSAR 2023, 2023 | | 2023 |
| Understanding how behaviour therapists use autism spectrum disorder diagnostic information for intervention planning I Caven, C Nguyen, J Wiegelmann, E Laframboise, M Penner Frontiers in Psychiatry 14, 2023 | | 2023 |
| Clinician Perspectives on the Acceptability of Pediatric ASD Therapies: A Mixed-Methods Study I Caven, M Penner AACAP/CACAP 2022 Annual Meeting, 2022 | | 2022 |
| Multi-Stakeholder Perspectives on Acceptability of Pediatric Autism Therapies: A Mixed Methods Study I Caven University of Toronto (Canada), 2022 | | 2022 |
| MP28-02 QUANTITATIVE MEASUREMENT OF PTEN LOSS IMPROVES RISK ASSESSMENT IN PROSTATE CANCER T Jamaspishvili*, P Patel, Y Niu, T Vidotto, I Caven, R Livergant, W Fu, ... The Journal of Urology 201 (Supplement 4), e403-e403, 2019 | | 2019 |
